Another study found that the subcutaneous injection of Apelin-13 (2 mg/kg) decreases serum superoxide dismutase (SOD) and glutathione peroxidase (GPx) expression in mice with GDM, which was found to significantly improve glucose and lipid metabolism disorders, oxidative stress, and inflammatory responses. Here, APLN is linked to gestational diabetes.